Advanced seminoma - Treatment results and prognostic factors for survival after first-line, cisplatin-based chemotherapy and for patients with recurrent disease: A single-institution experience in 145 patients

Cancer

Volumn 98, Issue 4, 2003, Pages 745-752

  Gholam, Dany ^a   Fizazi, Karim ^a   Terrier Lacombe, Marie Jose ^a   Jan, Pascale ^a   Culine, Stephane ^a   Theodore, Christine ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Advanced seminoma; First line chemotherapy; Prognostic factors; Salvage therapy

Indexed keywords

ANTINEOPLASTIC AGENT; CHORIONIC GONADOTROPIN; CISPLATIN; LACTATE DEHYDROGENASE;

ADULT; ADVANCED CANCER; ARTICLE; AUTOTRANSPLANTATION; BONE METASTASIS; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM METASTASIS; DRUG MEGADOSE; HUMAN; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SALVAGE THERAPY; SEMINOMA; STEM CELL TRANSPLANTATION; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR LOCALIZATION; VISCERAL METASTASIS;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CENTRAL NERVOUS SYSTEM NEOPLASMS; CISPLATIN; HUMANS; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SEMINOMA; SURVIVAL RATE; TESTICULAR NEOPLASMS;

EID: 0041570249     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.11574     Document Type: Article

References (29)

1. Willan B, McGowan D. Seminoma of the testis: a 22-year experience with radiation therapy. Int J Radiat Oncol Biol Phys. 1985;11:1769-1775.
2. Fossa S, Aass N, Kaalhus O. Radiotherapy for testicular seminoma stage I: treatment results and long-term post-irradiation morbidity in 365 patients. Int J Radiat Oncol Biol Phys. 1989;16:383-388.
3. Gregory C, Peckham M. Results of radiotherapy for stage II testicular seminoma. Radiother Oncol. 1986;6:285-292.
4. Warde P, Gospodarowicz M, Panzarella T, et al. Management of Stage II seminoma. J Clin Oncol. 1998;16:290-294.
5. Polansky SM, Barwick KW, Ravin CE. Primary mediastinal seminoma. Am J Radiol. 1979;12:17-21.
6. Fizazi K, Culine S, Droz JP, et al. Initial management of primary mediastinal seminoma: radiotherapy or cisplatin-based chemotherapy? Eur J Cancer. 1998;34:347-352.
7. Friedman E, Garnick M, Stomper P, et al. Therapeutic guidelines and results in advanced seminoma. J Clin Oncol. 1985; 3:1325-1332.
8. Loehrer P, Birch R, Williams S, Einhorn L. Chemotherapy of metastatic seminoma: the Southeastern Cancer Study Group experience. J Clin Oncol. 1987;5:1212-1220.
9. Logothetis CJ, Samuels ML, Ogden SL, et al. Cyclophosphamide and sequential cisplatin for advanced seminoma: long-term follow-up in 52 patients. J Urol. 1987;138:789-794.
10. Mencel P, Motzer R, Bajorin D, et al. Advanced seminoma: treatment results, survival, and prognostic factors in 142 patients. J Clin Oncol. 1994;12:120-126.
11. [No authors listed.] International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Consensus Group. J Clin Oncol. 1997;15:594-603.
12. Culine S, Theodore C, Droz JP, et al. Cisplatin-based chemotherapy in advanced seminoma: the Institut Gustave Roussy experience. Eur J Cancer. 1998;34:353-358.
13. Fossa SD, Droz JP, Stoter G, et al. Cisplatin, vincristine, and ifosphamide combination chemotherapy of metastatic seminoma: results of EORTC trial 30874. EORTC GU Group. Br J Cancer. 1995;71:619-624.
14. Miller K, Loehrer P, Einhorn L. Salvage chemotherapy with vinblastine, ifosfamide and cisplatin in recurrent seminoma. J Clin Oncol. 1997;15:1427-1431.
15. Motzer R, Mazumdar M, Bajorin D, Bosl G. High-dose carboplatin, etoposide, and cyclophosphamide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ cell tumors. J Clin Oncol. 1997; 15:2546-2552.
16. Grill J, Kalifa C, Droz F, et al. A high-dose busulfan-thiotepa combination followed by autologous bone marrow transplantation in childhood recurrent ependymoma. A Phase II study. Pediatr Neurosurg. 1996;25:7-12.
17. Lotz JP, Andre T, Donsimoni R, et al. High-dose chemotherapy with ifosfamide, carboplatin, and etoposide combined with autologous bone marrow transplantation for the treatment of poor-prognosis germ cell tumors and metastatic trophoblastic disease in adults. Cancer. 1995;76:154-155.
18. Fossa SD, Oliver RTD, Stenning SP, et al. Prognostic factors for patients with advanced seminoma treated with platinum-based chemotherapy. Eur J Cancer. 1997;33:1380-1387.
19. Peckham MJ, Horwich A, Hendry WF. Advanced seminoma: treatment with cisplatinum based combination chemotherapy or carboplatin (JM8). Br J Cancer. 1985;52:7-13.
20. Tjulandin SA, Khlebnov AV, Nasirova RJ, et al. VAB-6 and cisplatin-cyclophosphamide combinations in the treatment of metastatic seminoma patients: the USSR experience. Ann Oncol. 1991;2:667-672.
21. Bokemeyer C, Kollmannsberger C, Flechon A, et al. Prognostic factors in patients with advanced metastatic seminoma treated with either single agent carboplatin or cisplatin-based combination chemotherapy: a meta-analysis of prospective European trials [abstract 740]. Proc Am Soc Clin Oncol. 2002;21:186.
22. Bobba VS, Mittal BB, et al. Classical and anaplastic seminoma: difference in survival. Radiology. 1988;167:849-852.
23. Aubry F, Satie AP, Rioux-Leclercq N, et al. MAGE-A4, a germ cell specific marker, is expressed differentially in testicular tumors. Cancer. 2001;92:2778-2785.
24. Tickoo SK, Hutchinson B, Motzer RJ, et al. Testicular seminoma: a clinicopathologic and immunohistochemical study of 105 cases with specific reference to seminomas with atypical features. Int J Surg Pathol. 2002;10:23-32.
25. Vuky J, Tickoo S, Bajorin D, Bosl G, Motzer R. Salvage chemotherapy for patients with advanced pure seminoma. J Clin Oncol. 2002;20:297-301.
26. Motzer RJ, Bajorin DF, Schwartz LH, et al. Phase II trial of paclitaxel shows antitumor activity in patients with previously treated germ cell tumors. J Clin Oncol. 1994;12:2277-2283.
27. Motzer RJ, Mazumbar M, Sheinfeld J, et al. Sequential dose-intensive paclitaxel, ifosfamide, carboplatin, and etoposide salvage therapy for germ cell tumor patients. J Clin Oncol. 2000;18:1173-1180.
28. Rosti G, Pico JL, Wandt H, et al. High-dose therapy in the salvage treatment of patients failing first-line platinum chemotherapy for advanced germ cell tumors; first results of a prospective randomized trial of the European Group for Blood and Marrow Transplantation: IT-94 study. Proc Am Soc Clin Oncol. 2002;21:180.
29. Rick O, Siegert W, Schwella N, Krusch A, Beyer J. High-dose chemotherapy as salvage treatment for seminoma. Bone Marrow Transplant. 2002;30:157-160.